Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Mycotechnology Inc. operates a patent portfolio in the Biotechnology & Pharmaceuticals technology area. There are 2 pending office actions currently associated with this portfolio. These actions are distributed across 2 distinct art units, suggesting that the pending matters cover different technical aspects of biotechnology. The prosecution involves 2 distinct examiners. This distribution shows that the company's current patent applications are being reviewed by multiple individuals across different specialized units.
KARUNASENA, ENUSHA is the busiest examiner for Mycotechnology Inc. This examiner is currently responsible for 1 pending office action. With a total of 2 pending office actions, the workload is divided between the 2 distinct examiners. This means that KARUNASENA, ENUSHA is managing 1 of the company's current pending office actions. This distribution shows that no single examiner is managing more than 1 of the company's current pending office actions.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KARUNASENA, ENUSHA | 1 | 25.0% | +100.0% |
| MERRIAM, ANDREW E | 1 | 28.3% | +33.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18041048 | SUPPLEMENTAL CACAO FERMENTATION | MERRIAM, ANDREW E | 45d overdue |
| 18566975 | METHODS FOR THE PRODUCTION OF MYCELIAL BIOMASS FROM DATE EXTRACT | KARUNASENA, ENUSHA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18041048 | SUPPLEMENTAL CACAO FERMENTATION | MERRIAM, ANDREW E | 45d overdue |
| 18566975 | METHODS FOR THE PRODUCTION OF MYCELIAL BIOMASS FROM DATE EXTRACT | KARUNASENA, ENUSHA | — |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| 1791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18566975 | METHODS FOR THE PRODUCTION OF MYCELIAL BIOMASS FROM DATE EXTRACT | KARUNASENA, ENUSHA | 1653 | §103§112 | Non-Final OA | — | Pending | Dec 04, 2023 |
| 18041048 | SUPPLEMENTAL CACAO FERMENTATION | MERRIAM, ANDREW E | 1791 | §103§112 | Non-Final OA | 45d overdue | Pending | Feb 08, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMycotechnology Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Enusha Karunasena has the most, with 1 of Mycotechnology Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
